Work

Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured

Year: 2022

Type: article

Study design: Observational Study

Source: American Journal of Preventive Medicine

DOI: 10.1016/j.amepre.2022.03.010

Authors: Rachel L. Epstein, Jianing Wang, Laura F. White, Shashi N. Kapadia, Jake R. Morgan, Yuhua Bao, Benjamin P. Linas

Institutions: Boston University, Boston Medical Center, Weill Cornell Medicine

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: bronze

Funders: Gilead Sciences, Charles A. King Trust, National Institutes of Health, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases

Awards: G2464305517, G3333387759, Integrated Care for Hepatitis C: Current Uptake & Impact on Future Treatment, G5316515788, Providence/Boston Center for AIDS Research (CFAR), Researching Effective Strategies to Prevent Opioid Death (RESPOND), Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge Translation, BU Clinical HIV/AIDS Research Training Program (BU-CHART, Clinical Addiction Research and Education (CARE) Program

OpenAlex ID: W4283074911

FWCI: 0.892

Cites: 26

Cited by: 7

Related to: 10